Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22,967 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial.
Su J, Li M, He L, Zhao D, Wan W, Liu Y, Xu J, Xu J, Liu H, Jiang L, Wu H, Zuo X, Huang C, Liu X, Li F, Zhang Z, Liu X, Dong L, Li T, Chen H, Li J, He D, Lu X, Huang A, Tao Y, Wang Y, Zhang Z, Wei W, Li X, Zeng X. Su J, et al. Among authors: jiang l. BioDrugs. 2020 Jun;34(3):381-393. doi: 10.1007/s40259-020-00408-z. BioDrugs. 2020. PMID: 32078145 Free PMC article. Clinical Trial.
An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
Huang X, Du H, Gu J, Zhao D, Jiang L, Li X, Zuo X, Liu Y, Li Z, Li X, Zhu P, Li J, Zhang Z, Huang A, Zhang Y, Bao C. Huang X, et al. Among authors: jiang l. Int J Rheum Dis. 2014 Jul;17(6):679-86. doi: 10.1111/1756-185X.12266. Epub 2014 Jan 28. Int J Rheum Dis. 2014. PMID: 24467549 Clinical Trial.
Remission assessment of rheumatoid arthritis in daily practice in China: a cross-sectional observational study.
Zhu H, Li R, Da Z, Bi L, Li X, Li Y, Liu C, Zhang F, Li Z, Liu X, Zhang Z, Sun L, Wang Y, Zhang W, Jiang Q, Chen J, Chen Q, Li Z, Wu L, Qi W, Xu J, Cui X, Wang X, Li L, Leng X, Wang G, Zhao D, Jiang L, He D, Liu X, Li L, Fang Y, Huang C, Wu H, Hu S, Li Q, Song H, Xiao W, Gong L, Zhang L, Li X, Li Z, Su Y. Zhu H, et al. Among authors: jiang q, jiang l. Clin Rheumatol. 2018 Mar;37(3):597-605. doi: 10.1007/s10067-017-3850-z. Epub 2017 Nov 7. Clin Rheumatol. 2018. PMID: 29116543
Smoking quantity determines disease activity and function in Chinese patients with ankylosing spondylitis.
Zhang H, Wan W, Liu J, Dai S, Zou Y, Qian Q, Ding Y, Xu X, Ji H, He H, Zhu Q, Yang C, Ye S, Jiang L, Tang J, Tong Q, He D, Zhao D, Li Y, Ma Y, Zhou J, Mei Z, Chen X, Yuan Z, Zhang J, Wang X, Yang Y, Jin L, Gao Y, Zhou X, Reveille JD, Zou H, Wang J. Zhang H, et al. Among authors: jiang l. Clin Rheumatol. 2018 Jun;37(6):1605-1616. doi: 10.1007/s10067-018-4016-3. Epub 2018 Mar 27. Clin Rheumatol. 2018. PMID: 29589132
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study.
Bi L, Li Y, He L, Xu H, Jiang Z, Wang Y, Li X, Wei W, Gu J, Wang G, Zhang Z, Zhou B, Liu Y, Wu Z, Liu H, He D, Lv Z, Li Z, Zuo X, Dong L, Wu H, Zhang H, Chen H, Bao C, Zhang Z, Zhang M, Song H, Zheng Y, Jiang L, Liu X, Boehnlein M, Dunkel J, Shao J, Harris K, Li Z. Bi L, et al. Among authors: jiang l, jiang z. Clin Exp Rheumatol. 2019 Mar-Apr;37(2):227-234. Epub 2018 Aug 29. Clin Exp Rheumatol. 2019. PMID: 30183595 Free article. Clinical Trial.
Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points.
Su J, Li M, He L, Zhao D, Wan W, Liu Y, Xu J, Xu J, Liu H, Jiang L, Wu H, Zuo X, Huang C, Liu X, Li F, Zhang Z, Liu X, Dong L, Li T, Chen H, Li J, He D, Lu X, Huang A, Tao Y, Wang Y, Zhang Z, Wei W, Li X, Zeng X. Su J, et al. Among authors: jiang l. Front Pharmacol. 2020 Dec 7;11:606497. doi: 10.3389/fphar.2020.606497. eCollection 2020. Front Pharmacol. 2020. PMID: 33364967 Free PMC article.
Efficacy and safety of a selective URAT1 inhibitor SHR4640 in Chinese subjects with hyperuricaemia: a randomized controlled phase II study.
Lin Y, Chen X, Ding H, Ye P, Gu J, Wang X, Jiang Z, Li D, Wang Z, Long W, Li Z, Jiang G, Li X, Bi L, Jiang L, Wu J, Guo L, Cai X, Lu X, Chen Q, Chen H, Peng A, Zuo X, Ning R, Zhang Z, Tai Y, Zhang T, Bao C. Lin Y, et al. Among authors: jiang g, jiang l, jiang z. Rheumatology (Oxford). 2021 Nov 3;60(11):5089-5097. doi: 10.1093/rheumatology/keab198. Rheumatology (Oxford). 2021. PMID: 33693494 Clinical Trial.
22,967 results
You have reached the last available page of results. Please see the User Guide for more information.